Search Results

India’s drug regulator introduces new measures to improve monitoring of the supply chain for pharmaceutical solvents following the Coldrif cough syrup tragedy

After finding FatX was being marketed under claims it could dissolve fat cells, the regulator said this was not suitable for registration as a cosmetic product under the Drugs and Cosmetics Act, 1940

WHO sensitized India’s Central Drugs Standard Control Organization over a suspected batch of counterfeit Defitelio circulating in the market

Glenmark Launches DCGI-Approved Brukinsa to Transform Blood Cancer Treatment in India

Approximately three million people receive anti-rabies vaccines in India each year, CDSCO under the DCGI overviews the manufacture and distribution of these drugs

CDSCO suspended HCG-Bangalore's Ethics Committee for 24 months after finding nine unreported adverse events, including three deaths. Here's what it means for clinical trial patients in India.